Release Date: 27/04/16 11:40 Summary: Intended Move to ASX Price Sensitive: No Download Document Not available as of the moment. Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%